In Brief:
New animal research has identified a sequence of genetic material that appears to stabilize levels of so-called " In turn, if the sequence is "silenced," HDL levels go up, according to study co-authors Katey Rayner and Kathryn Moore, both of New York University Medical Center in New York City.. Rayner and Moore are slated to present their findings Tuesday in Chicago at the annual meeting of the American Heart Association.. Their observations are part of an effort to develop new treatments designed to elevate HDL levels.. Working with mice suffering from coronary artery disease, the researchers found that inhibiting the identified sequence prompted a 36 percent rise in HDL levels..
